10 Mar 2022 Confo Therapeutics doses first subjects in Phase 1 clinical trial of CFTX-1554 for the treatment of neuropathic pain Member news
08 Mar 2022 MyCellHub strengthens its growth ambitions by appointing Jacques Parlongue as CEO Member news
08 Mar 2022 KU Leuven’s Biosensors group develops first label-free assay characterizing COVID-19 antibodies directly in patient blood, using FOx BIOSYSTEMS platform Member news
08 Mar 2022 UCB expands innovation footprint with new state-of-the-art gene therapy facility Member news
02 Mar 2022 V-Bio Ventures’ portfolio company Syndesi Therapeutics acquired by AbbVie to strengthen its neuroscience portfolio Member news
28 Feb 2022 2.3 million grant awarded to Flen Health by the Ministry of the Economy of Luxembourg (MECO) Member news
More info? Ellen Telleir Communications Project Manager linkedin.com/in/ellentelleir/ ellen.telleir@biovia.be Contact us
